CONTEXT: Commercial announcement – Syneos expands its decentralised trial offering
IMPACT: Low
READ TIME: 1 min
Quality Level Mean [1 – 10]: 3
” TRIALS & FILINGS Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial NVX-CoV2373 demonstrates 100% protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint.”